| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New Method to Determine the Optimal Willingness to Pay in Cost-Effectiveness Analysis
|
Phelps, Charles E.
|
|
2019
|
22 |
7 |
p. 785-791
|
artikel
|
| 2 |
Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States
|
Zhao, Jingxuan
|
|
2019
|
22 |
7 |
p. 762-767
|
artikel
|
| 3 |
Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2
|
Poder, Thomas G.
|
|
2019
|
22 |
7 |
p. 837-842
|
artikel
|
| 4 |
Copyright/Subscription
|
|
|
2019
|
22 |
7 |
p. iv
|
artikel
|
| 5 |
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States
|
|
|
2019
|
22 |
7 |
p. 843
|
artikel
|
| 6 |
Editorial Board
|
|
|
2019
|
22 |
7 |
p. v
|
artikel
|
| 7 |
Evolving Use of Real-World Evidence for Devices: Good for Patients, Good for Policy Makers
|
Mullins, C. Daniel
|
|
2019
|
22 |
7 |
p. 751-753
|
artikel
|
| 8 |
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma
|
Li, Meng
|
|
2019
|
22 |
7 |
p. 777-784
|
artikel
|
| 9 |
How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence
|
Yang, Zhihao
|
|
2019
|
22 |
7 |
p. 829-836
|
artikel
|
| 10 |
Impact of Nonrandomized Dropout on Treatment Switching Adjustment in the Relapsing–Remitting Multiple Sclerosis CLARITY Trial and the CLARITY Extension Study
|
Gorrod, Helen Bell
|
|
2019
|
22 |
7 |
p. 772-776
|
artikel
|
| 11 |
ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products
|
O'Neill, Tyler
|
|
2019
|
22 |
7 |
p. 754-761
|
artikel
|
| 12 |
Machine Learning for Health Services Researchers
|
Doupe, Patrick
|
|
2019
|
22 |
7 |
p. 808-815
|
artikel
|
| 13 |
Parent Proxy Discrepancy Groups of Quality of Life in Childhood Epilepsy
|
Fayed, Nora
|
|
2019
|
22 |
7 |
p. 822-828
|
artikel
|
| 14 |
Reconciling the Seemingly Irreconcilable: How Much Are We Spending on Drugs?
|
Kleinrock, Michael
|
|
2019
|
22 |
7 |
p. 792-798
|
artikel
|
| 15 |
Table of Contents
|
|
|
2019
|
22 |
7 |
p. i-iii
|
artikel
|
| 16 |
The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory
|
Lipman, Stefan A.
|
|
2019
|
22 |
7 |
p. 816-821
|
artikel
|
| 17 |
Time-Driven Activity-Based Costing in Urologic Surgery Cycles of Care
|
McClintock, Tyler R.
|
|
2019
|
22 |
7 |
p. 768-771
|
artikel
|
| 18 |
Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?
|
Pouwels, Xavier G.L.V.
|
|
2019
|
22 |
7 |
p. 799-807
|
artikel
|
Tijdschrift beschrijving